Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Liquidity Position ⢠Weak Interest Coverage ⢠High Intangible Exposure NEOG has strong liquidity and positive cash flow, but weak profitability, poor interest coverage, and high intangible assets make debt servicing and earnings recovery key risks.
Price Behavior
Key Price Behavior Insights: ⢠Modest monthly gain ⢠Key support holding ⢠Breakout needed Support Level: $11.60â$11.65 (stronger: $11.40â$11.47) Resistance Level: $11.95â$12.15 NEOG is cautiously positive over the last month, holding above $11.60 support but needing a breakout above $12.15 to strengthen momentum.
Sentiment & News
Key News Insights: ⢠Earnings revisions ⢠Institutional buying ⢠Safety recovery Neogen's strong share momentum, earnings revisions, and new institutional buying support a positive outlook, though investors should monitor execution risks in Animal Safety.
AI Summary
NEOG is now a leveraged execution-recovery investmentânot a dependable compounderâwhere Food Safety momentum and Animal Safety supply normalization could lift margins and cash flow, but the already-rich valuation leaves little tolerance for further operational disruption or weak interest coverage. Investors should wait for sustained Animal Safety recovery, margin expansion, and debt reduction before treating the rebound as durable.
Description
Neogen Corporation develops, manufactures and sells products used to detect, mitigate and monitor biological, chemical and sanitary hazards across the food and animal sectors. Its Food Safety business supplies diagnostic test kits and sanitation assays to food and feed producers, processors, grain handlers, dairies, laboratories and related manufacturers to identify pathogens, toxins, residues, allergens and other contaminants, while its Animal Safety business provides veterinary medicines, vaccines, diagnostic tools, disinfectants and genomics services, including drug-residue and toxicology testing for animals. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jan 1 | Jan 8 | NEOG | Neogen Corporation | Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential. | Closed | +38.9% |